Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DIOVAN

VALSARTAN

Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview DIOVAN is listed in Drugs@FDA under application 020665 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient VALSARTAN Form and strength CAPSULE;ORAL - 80MG Sponsor NOVARTIS Submission history Latest submission status date: 2017-02-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIOVAN is listed in Drugs@FDA under application 020665 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VALSARTAN Form and strength CAPSULE;ORAL - 80MG Sponsor NOVARTIS Submission history Latest submission status date: 2017-02-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.